| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |